| Filed On | Filing |
|---|---|
| 18 Sep 2026 |
Form 4: Nagel Robert Thorvald, Director
Granted 25,370 Stock Option |
| 18 Sep 2026 |
Form 4: Bvf Partners L P/IL, Director and 9 others
Granted 25,370 Stock Option |
| 10 Aug 2026 |
Form 4: Ridloff Elena, Director
Granted 50,740 Stock Option |
| 07 Jul 2026 |
Form 4: Skerjanec Simona, Director
Granted 25,370 Stock Option |
| 07 Jul 2026 |
Form 4: Rudick Richard Alan, Director
Granted 25,370 Stock Option |
| 07 Jul 2026 |
Form 4: Phillips Barclay A, Director
Granted 25,370 Stock Option |
| 07 Jul 2026 |
Form 4: Neermann Joerg, Director
Granted 25,370 Stock Option |
| 07 Jul 2026 |
Form 4: Congleton Jon, Director
Granted 25,370 Stock Option |
| 29 Jun 2026 |
Form 4: Congleton Jon, Director
Granted 50,740 Stock Option |
| 29 Jun 2026 |
Form 4: Skerjanec Simona, Director
Granted 25,370 Stock Option |
| 29 Jun 2026 |
Form 4: Rudick Richard Alan, Director
Granted 25,370 Stock Option |
| 29 Jun 2026 |
Form 4: Howson Tamar D, Director
Granted 25,370 Stock Option |
| 29 Jun 2026 |
Form 4: Neermann Joerg, Director
Granted 25,370 Stock Option |
| 29 Jun 2026 |
Form 4: Phillips Barclay A, Director
Granted 25,370 Stock Option |
| 29 Jun 2026 |
Form 4: Whaley Glenn, Chief Financial Officer
Granted 120,000 Stock Option |
| 29 Jun 2026 |
Form 4: Vitt Daniel, Director
Granted 445,000 Stock Option |
| 29 Jun 2026 |
Form 4: Bonney Michael W, Director
Granted 100,000 Stock Option |
| 29 Jun 2026 |
Form 4: Tardio Jason, President and COO
Granted 253,000 Stock Option |
| 01 Jun 2026 |
Form 4: Lundgren Erik, Chief Executive Officer
Granted 1,000,000 Stock Option |
| 29 Apr 2026 |
Form 4: Panzara Michael A., Chief Medical Officer
Granted 300,000 Stock Option |
Loading...